Desjardins Global Asset Management Inc. Exact Sciences Corp Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 903 shares of EXAS stock, worth $39,867. This represents 0.01% of its overall portfolio holdings.
Number of Shares
903
Previous 641
40.87%
Holding current value
$39,867
Previous $43,000
53.49%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EXAS
# of Institutions
667Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$774 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$751 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$533 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$275 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$254 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.81B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...